Blog
RSS FeedPosted by Michael Wonder on 26 Jul 2017
The price of crossing the border for medications
27 July 2017 - Canadians are used to paying more for identical products sold south of the border. ...
Posted by Michael Wonder on 26 Jul 2017
Price transparency in medicine faces stiff opposition — from hospitals and doctors
25 July 2017 - Two years after it passed unanimously in Ohio’s state Legislature, a law meant to inform patients ...
Posted by Michael Wonder on 26 Jul 2017
Trump's FDA Commissioner on drug prices, regulations, science
25 July 2017 - U.S. FDA Commissioner Scott Gottlieb spoke with Bloomberg News about drug pricing, new medicine and regulations. ...
Posted by Michael Wonder on 26 Jul 2017
Institute for Clinical and Economic Review announces potential topics for review in 2018
26 July 2017 - Tentative list includes drugs for migraines, haemophilia, and cystic fibrosis. ...
Posted by Michael Wonder on 26 Jul 2017
A bid for HHS to override patents on pricey drugs is shot down
25 July 2017 - File this under “Nice try, but … ...
Posted by Michael Wonder on 26 Jul 2017
Senate GOP measure to repeal and replace Obamacare fails
26 July 2017 - Senate Republicans overcame a range of internal fissures in narrowly voting on Tuesday to begin debate ...
Posted by Michael Wonder on 26 Jul 2017
UCB and Dermira announce U.S. and EU regulatory submissions for Cimzia (certolizumab pegol) for the treatment of moderate-to-severe chronic plaque psoriasis
25 July 2017 - The regulatory submissions for this new indication seek to expand the use of Cimzia for the treatment ...
Posted by Michael Wonder on 26 Jul 2017
FDA grants fast track designation to Flex Pharma’s FLX-787 for the treatment of severe muscle cramps associated with AL
25 July 2017 - Prioritising US phase 2 COMMEND trial; exploratory Australian ALS study to end early. ...
Posted by Michael Wonder on 26 Jul 2017
Orchard Therapeutics announces that OTL-101 has received a rare paediatric disease designation
25 July 2017 - Orchard Therapeutics is delighted to announce today that the US FDA granted a rare paediatric disease designation ...
Posted by Michael Wonder on 25 Jul 2017
Dr Steve Pearson on using health technology assessment to guide decision making
23 July 2017 - Health technology assessment is a tool that helps to objectively evaluate evidence, which levels the playing field ...
Posted by Michael Wonder on 25 Jul 2017
Practical improvements for medical device evaluation
25 July 2017 - Passage of the Medical Device Amendments Act in 1976 confirmed the US FDA’s primary responsibility for evaluating ...
Posted by Michael Wonder on 25 Jul 2017
Democrats, recycling old ideas, call for a federal ‘enforcer’ to tackle drug price gouging
24 July 2017 - Seeking to gain momentum on a populist issue, congressional Democrats on Monday released a blueprint for ...
Posted by Michael Wonder on 25 Jul 2017
Yes, we can lower sky-high drug prices — other countries have done it
25 July 2017 - Scott Gottlieb, head of the FDA, wasted no time in his opening remarks at a forum ...
Posted by Michael Wonder on 25 Jul 2017
McCain returns for Obamacare vote
25 July 2017 - At the twilight of his career and battling a brain tumour, Senator John McCain stands poised ...
Posted by Michael Wonder on 25 Jul 2017
ICER seeks public comment on proposed value assessment framework for treatments that represent a potential major advance for serious ultra-rare conditions
25 July 2017 - ICER’s fundamental approach to value assessment remains constant with proposed changes for special circumstances. ...